Eli Lilly conducted phase III clinical trials on Cymbalta from July 2009 to May 2010. The study enrolled 420 patients and compared the efficacy of 60mg of Cymbalta to a placebo to assess the effect of the drug in reducing the pain effect caused by knee osteoarthritis.
-
Eli Lilly's Cymbalta (Duloxetine hydrochloride) is used to treat chronic... -
Cymbalta contains a selective serotonin and norepinephrine reuptake inhibitor... -
Eli Lilly conducted phase III clinical trials on Cymbalta from July 2009 to...
Twitter
Facebook